Integration of bisphosphonates into adjuvant therapy regimens for early breast cancer
Clinical updates in translational science
Interpretation and integration of recent clinical trial data into clinical practice
Pharmacogenomics and effects on drug interactions, efficacy and safety
Combinations of hormonal and biologic agents
Appropriate use of anthracyclines in early breast cancer
Treatment of pre- and-postmenopausal women with hormone receptor-positive breast cancer
Management of patients with relapsed HER2-positive breast cancer
Potential role for EGFR targeted therapy in breast cancer
Novel cytotoxic agents for breast cancer
Management of triple negative/basal type breast cancer
Monitoring and managing the cardiotoxicity of systemic therapeutic agents
Optimal use of lapatinib in patients with HER2-positive metastatic breast cancer
Mechanisms and management of trastuzumab resistance
Conference Objectives: Great Debates and Updates in Breast Cancer will be a world class medical education forum for the exchange of critical information in the field of breast cancer. It features didactic presentations and a debate format, in which distinguished faculty discuss some of the most challenging topics in breast cancer.
Who Should Attend: Medical Oncologists, Radiation Oncologists, Surgical Oncologists, Nurses, Fellows, and Residents.
Registration Information: To pre-register, registration and payment must be received no later than June 11, 2009. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure that the program is being held as scheduled and to confirm that the meeting is not full.
Mar 27, 2014 - The American Society of Clinical Oncology has updated its clinical practice guideline on the use of sentinel node biopsy in early breast cancer. The updated guideline was published online March 24 in the Journal of Clinical Oncology.